Showing 1 - 8 results of 8 for search 'Anna Piekarska', query time: 0.05s Refine Results
  1. 1
    Editorial

    Editorial by Anna Piekarska

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Poland's Politics of History since 1989. Considerations - Challenges - Tools - Goals. Warsaw, June 12, 2018

    Poland's Politics of History since 1989. Considerations - Challenges - Tools - Goals. Warsaw, June 12, 2018 by Rafał Chwedoruk, Franciszek Dąbrowski, Maciej Korkuć, Andrzej Nowak, Anna Piekarska, Włodzimierz Suleja

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    “…The Phrase that »History Does Not Matter to the Present Day« Was Never More Deceptive than It Is Now.”

    “…The Phrase that »History Does Not Matter to the Present Day« Was Never More Deceptive than It Is Now.” by Daniel Boćkowski, Franciszek Dąbrowski, Marek Kornat, Łukasz Jasina, Filip Musiał, Anna Piekarska, Witold Wasilewski

    Published 2021-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Railway Infrastructure as a Substitute Habitat for Valuable Medicinal Plant Species Using the Example of Bearberry <i>Arctostaphylos uva-ursi</i>

    Railway Infrastructure as a Substitute Habitat for Valuable Medicinal Plant Species Using the Example of Bearberry <i>Arctostaphylos uva-ursi</i> by Barbara Bacler-Żbikowska, Agnieszka Hutniczak, Wojciech Bierza, Jawdat Bakr, Agnieszka Błońska, Anna Piekarska-Stachowiak, Paweł Olszewski, Anna Pieprzyca, Piotr Kucharski, Adam Stebel, Gabriela Woźniak

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide

    Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide by Aleksandra Berkan-Kawińska, Anna Piekarska, Hanna Berak, Włodzimierz Mazur, Aleksander Garlicki, Magdalena Tudrujek-Zdunek, Beata Lorenc, Dorota Dybowska, Łukasz Socha, Anna Parfieniuk-Kowerda, Robert Flisiak

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination

    Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination by Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Correction: Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination

    Correction: Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination by Dorota Zarębska-Michaluk, Michał Brzdęk, Olga Tronina, Justyna Janocha-Litwin, Marek Sitko, Anna Piekarska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Barbara Sobala-Szczygieł, Magdalena Tudrujek-Zdunek, Łukasz Laurans, Robert Flisiak

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes

    Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes by Michał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, Beata Lorenc, Justyna Janocha-Litwin, Hanna Berak, Krzysztof Tomasiewicz, Marek Sitko, Włodzimierz Mazur, Ewa Janczewska, Dorota Dybowska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz, Anna Piekarska, Robert Flisiak

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: